Details of the Target
General Information of Target
Target Site Mutations in Different Cell Lines
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
A-EBA Probe Info |
![]() |
9.79 | LDD0214 | [1] | |
IBr-1b Probe Info |
![]() |
C481(20.00) | LDD0306 | [2] | |
IA-alkyne Probe Info |
![]() |
C527(1.39) | LDD0304 | [3] | |
DBIA Probe Info |
![]() |
C536(3.85); C371(2.36); C97(3.73); C498(3.69) | LDD3333 | [4] |
PAL-AfBPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
FFF probe11 Probe Info |
![]() |
7.95 | LDD0472 | [5] | |
FFF probe13 Probe Info |
![]() |
13.60 | LDD0476 | [5] | |
FFF probe3 Probe Info |
![]() |
11.85 | LDD0465 | [5] | |
VE-P Probe Info |
![]() |
N.A. | LDD0396 | [6] | |
Dasatinib-CA-3PAP Probe Info |
![]() |
N.A. | LDD0365 | [7] | |
Dasatinib-CA-8PAP Probe Info |
![]() |
N.A. | LDD0364 | [7] | |
DA-2 Probe Info |
![]() |
N.A. | LDD0070 | [8] | |
STS-1 Probe Info |
![]() |
N.A. | LDD0068 | [9] |
Competitor(s) Related to This Target
Competitor ID | Name | Cell line | Binding Site(Ratio) | Interaction ID | Ref |
---|---|---|---|---|---|
LDCM0097 | Dasatinib | K562 | N.A. | LDD0364 | [7] |
LDCM0625 | F8 | Ramos | C464(1.52); C527(0.61); C337(4.46) | LDD2187 | [10] |
LDCM0572 | Fragment10 | Ramos | C464(0.46); C527(0.93); C165(0.93) | LDD2189 | [10] |
LDCM0573 | Fragment11 | Ramos | C464(2.17); C337(20.00) | LDD2190 | [10] |
LDCM0574 | Fragment12 | Ramos | C464(0.86); C527(0.59); C165(0.41) | LDD2191 | [10] |
LDCM0575 | Fragment13 | Ramos | C527(0.76); C165(1.01) | LDD2192 | [10] |
LDCM0576 | Fragment14 | Ramos | C165(0.85); C337(0.73) | LDD2193 | [10] |
LDCM0579 | Fragment20 | Ramos | C464(0.46); C527(0.57); C165(0.64) | LDD2194 | [10] |
LDCM0580 | Fragment21 | Ramos | C527(0.67); C165(0.83) | LDD2195 | [10] |
LDCM0582 | Fragment23 | Ramos | C527(0.67); C165(0.57) | LDD2196 | [10] |
LDCM0578 | Fragment27 | Ramos | C527(0.84); C165(0.87) | LDD2197 | [10] |
LDCM0586 | Fragment28 | Ramos | C527(0.88); C165(0.71) | LDD2198 | [10] |
LDCM0588 | Fragment30 | Ramos | C464(0.88); C527(0.58); C165(0.96) | LDD2199 | [10] |
LDCM0589 | Fragment31 | Ramos | C527(1.10); C165(1.13) | LDD2200 | [10] |
LDCM0590 | Fragment32 | Ramos | C464(0.43); C527(0.30); C165(0.35) | LDD2201 | [10] |
LDCM0468 | Fragment33 | Ramos | C464(0.37); C527(0.31); C165(0.53) | LDD2202 | [10] |
LDCM0596 | Fragment38 | Ramos | C464(1.13); C527(0.53); C165(0.84) | LDD2203 | [10] |
LDCM0566 | Fragment4 | Ramos | C527(0.32); C337(0.31) | LDD2184 | [10] |
LDCM0610 | Fragment52 | Ramos | C527(0.90); C165(0.94) | LDD2204 | [10] |
LDCM0614 | Fragment56 | Ramos | C464(2.14); C527(0.98) | LDD2205 | [10] |
LDCM0569 | Fragment7 | Ramos | C464(0.85); C527(0.84); C337(0.19) | LDD2186 | [10] |
LDCM0571 | Fragment9 | Ramos | C464(0.38); C527(0.68); C165(0.53) | LDD2188 | [10] |
LDCM0022 | KB02 | Ramos | C464(1.41); C527(0.99); C337(0.48) | LDD2182 | [10] |
LDCM0023 | KB03 | Ramos | C464(0.48); C527(0.56); C337(0.41) | LDD2183 | [10] |
LDCM0024 | KB05 | MOLM-13 | C536(3.85); C371(2.36); C97(3.73); C498(3.69) | LDD3333 | [4] |
LDCM0131 | RA190 | MM1.R | C527(1.39) | LDD0304 | [3] |
The Interaction Atlas With This Target
The Protein(s) Related To This Target
Enzyme
Transporter and channel
Protein name | Family | Uniprot ID | |||
---|---|---|---|---|---|
Heat shock protein HSP 90-beta (HSP90AB1) | Heat shock protein 90 family | P08238 | |||
Myelin and lymphocyte protein (MAL) | MAL family | P21145 |
Transcription factor
Other
Protein name | Family | Uniprot ID | |||
---|---|---|---|---|---|
SH3 domain-binding protein 5 (SH3BP5) | SH3BP5 family | O60239 | |||
Actin nucleation-promoting factor WAS (WAS) | . | P42768 | |||
B-cell linker protein (BLNK) | . | Q8WV28 |
The Drug(s) Related To This Target
Approved
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Dasatinib | Small molecular drug | DB01254 | |||
Fostamatinib | Small molecular drug | DB12010 | |||
Ibrutinib | Small molecular drug | D09KTS | |||
Acalabrutinib | . | D09PQZ | |||
Zanubrutinib | . | D0UT4W |
Phase 3
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Icp-022 | Small molecular drug | DUTJ12 | |||
Pirtobrutinib | Small molecular drug | DXP04H | |||
Gdc-0853 | . | D0A9PN |
Phase 2
Phase 1
Preclinical
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Pci-45292 | . | D0D4AQ |
Investigative
Patented
Discontinued
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Gdc-0834 | Small molecular drug | D03FUO |
References